10.1186/2228-5326-3-36

In vitro anticancer evaluation of 5-fluorouracil lipid nanoparticles using B16F10 melanoma cell lines

  1. Department Pharmacy, M S University of Baroda, Gujarat, 390 002, IN
  2. Department of Chemotherapy, Tata Memorial Center, Cancer Research Institute, Navi Mumbai, 410208, IN
Cover Image

Published in Issue 2013-05-17

How to Cite

Shenoy, V. S., Gude, R. P., & Murthy, R. S. R. (2013). In vitro anticancer evaluation of 5-fluorouracil lipid nanoparticles using B16F10 melanoma cell lines. International Nano Letters, 3(1 (December 2013). https://doi.org/10.1186/2228-5326-3-36

PDF views: 141

HTML views: 31

Abstract

Abstract The present study is aimed to investigate the formulation and in vitro anticancer activities of solid lipid nanoparticles (SLNs) of 5-fluorouracil (5-FU) prepared using glyceryl monostearate (GMS) and cetyl palmitate (CP) by hot homogenization method. The lipids were selected based on the partition coefficient of 5-FU in lipids. The lipid nanoparticles were optimized for process and formulation parameters. The optimized nanoparticles were characterized for their zeta potential, morphology, release kinetics, and anticancer activity. Higher entrapments were achieved using a combination of emulsifiers. The zeta potential of the optimized CP and GMS SLN formulation were −8.26 and −9.35 mV, respectively. Both the optimized formulations were spherical. The in vitro release studies of SLNs of both the lipid carriers followed Peppas-Korsenmeyer equation when carried out at pH 3.5 and 7.4. The chemosensitivity assay carried out in B16F10 cell lines revealed that CP SLNs had better cytotoxicity than 5-FU solution and GMS SLNs at 48 h of incubation. Subtoxic concentration of 5-FU-loaded CP SLNs (0.12 μg/mL) possessed comparable antimigrational activity, colony inhibition activity, and cytopathic as that of 5-FU solution effects. The results indicated that encapsulating 5-FU in CP would be a promising delivery system for delivering 5-FU.

Keywords

  • Cell morphology,
  • Cetyl palmitate,
  • Chemosensitivity assay,
  • Colony formation,
  • Glyceryl monostearate,
  • Hot homogenization

References

  1. Grem et al. (1996) Lippincott-Raven
  2. Grem et al. (1999) https://doi.org/10.1016/S0006-2952(99)00099-4
  3. McEnvoy et al. (1998) American Society of Health-System Pharmacists, Inc
  4. van Kuilenburg et al. (2000)
  5. Di Paolo et al. (2001) https://doi.org/10.1023/A:1012294617392
  6. Heggie et al. (1987)
  7. Jenning et al. (2002) https://doi.org/10.1080/713817583
  8. Mao et al. (2005)
  9. Jain et al. (2008) https://doi.org/10.1080/02652040701799598
  10. Hitzman et al. (2006) https://doi.org/10.1002/jps.20591
  11. Hitzman et al. (2006) https://doi.org/10.1002/jps.20590
  12. Du et al. (2010) https://doi.org/10.3109/10837450903246390
  13. Yassin et al. (2010) https://doi.org/10.7150/ijms.7.398
  14. Muller et al. (2000) https://doi.org/10.1016/S0939-6411(00)00087-4
  15. zur Muhlen et al. (1998) https://doi.org/10.1016/S0939-6411(97)00150-1
  16. Venkateswarlu and Manjunath (2004) https://doi.org/10.1016/j.jconrel.2004.01.005
  17. Griffioen and Molema (2000)
  18. Sungkaworn et al. (2007)
  19. Wolf et al. (2009) https://doi.org/10.1016/j.ejpb.2009.03.009
  20. Zhu et al. (2009) https://doi.org/10.1088/0957-4484/20/5/055702
  21. Qi et al. (2005)